Wuxi Bio to Sell Vaccine Facility to Merck

WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.
MSD acquires WuXi's vaccine facility in Dundalk for €500m
The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate geopolitical tensions.
Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over $500 Million
MSD acquires WuXi Vaccines' Dundalk facility with a €500 million investment, creating 1,000 new jobs across Ireland and expanding its vaccine production capabilities.
China's WuXi Biologics to sell Irish vaccine facility to Merck for €500m
China's WuXi Biologics has confirmed it will sell its vaccine facility in Ireland to US drugmaker Merck & Co for about €500 million. The WuXi Biologics facility is located in Dundalk, Co Louth, in the IDA Science and Technology Park.
In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics
In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey company was a natural buyer of the facility as it was the lone client WuXi Biologics served at the site in Dundalk, executing a 20-year contract to produce vaccines worth $150 million annually.
RTE Online3d
MSD Ireland agrees deal to buy WuXi Vaccines' Dundalk site
Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its ...
Dundalk Democrat19h
Wuxi employees make generous donation to St Vincent De Paul Dundalk
WuXi Biologics employees have once again exemplified their deep-rooted commitment to the local community, delivering ...
Drug giant MSD buys Wuxi’s Irish vaccines plant in €500m deal
US pharmaceutical group adds eighth Irish manufacturing site to its network as it promises to deliver 1,000 jobs this year ...
FiercePharma1h
Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...